Wellmatix Named Semifinalist in PharmStars Accelerator Fall Cohort
Published on August 20, 2025
Author: Wellmatix
Wellmatix has been selected as a semifinalist for the PharmStars Accelerator Fall Cohort, a key recognition of the company’s growing role in advancing pharmaceutical innovation.
The program brings together startups and industry leaders to drive collaboration in the pharmaceutical sector. As part of this milestone, Wellmatix will further develop its AI-driven solutions, engage with pharma stakeholders, and explore partnerships aimed at shaping the future of drug discovery and development.
The company expressed its appreciation to the PharmStars team for the opportunity and looks forward to contributing to the accelerator’s mission of fostering innovation in pharma.
The program brings together startups and industry leaders to drive collaboration in the pharmaceutical sector. As part of this milestone, Wellmatix will further develop its AI-driven solutions, engage with pharma stakeholders, and explore partnerships aimed at shaping the future of drug discovery and development.
The company expressed its appreciation to the PharmStars team for the opportunity and looks forward to contributing to the accelerator’s mission of fostering innovation in pharma.